About this Journal Submit a Manuscript Table of Contents
ISRN Oncology
Volume 2013 (2013), Article ID 675051, 8 pages
http://dx.doi.org/10.1155/2013/675051
Clinical Study

Cell Proliferation (KI-67) Expression Is Associated with Poorer Prognosis in Nigerian Compared to British Breast Cancer Women

1Department of Morbid Anatomy and Histopathology, Olabisi Onabanjo University, Sagamu, Nigeria
2Specialist Laboratory, Idi-Araba, Lagos, Nigeria
3Department of Surgery, Olabisi Onabanjo University, Sagamu, Nigeria
4Department of Medical Microbiology and Parasitology, Olabisi Onabanjo University, Sagamu, Nigeria
5School of Molecular Medical Science, Oncology Unit, University of Nottingham, Nottingham, UK

Received 25 February 2013; Accepted 14 March 2013

Academic Editors: Y. Akiyama, Z. S. Guo, and Y. Yamamoto

Copyright © 2013 Ayodeji O. J. Agboola et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [2 citations]

The following is the list of published articles that have cited the current article.

  • Ayodeji Agboola, Adewale Musa, Adekumbiola Banjo, Babatunde Ayoade, Mopelola Deji-Agboola, Christopher Nolan, Emad Rakha, Ian Ellis, and Andrew Green, “PIAS gamma expression in relation to clinicopathological, tumour factors and survival in indigenous black breast cancer women,” Journal of Clinical Pathology, vol. 67, no. 4, pp. 301–306, 2014. View at Publisher · View at Google Scholar
  • A. O. J. Agboola, A. A. Musa, B. A. Ayoade, A. A. Banjo, C. C. Anunobi, A. M. Deji-Agboola, E. A. Rakha, C. Nolan, I. O. Ellis, and A. R. Green, “Clinicopathological and molecular significance of Sumolyation marker (ubiquitin conjugating enzyme 9 (UBC9)) expression in breast cancer of black women,” Pathology Research and Practice, vol. 210, no. 1, pp. 10–17, 2014. View at Publisher · View at Google Scholar